13.30
+0.06
+(0.45%)
At close: January 16 at 8:11:19 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-19,769.00
-19,769.00
21,712.00
87,213.00
100,425.00
Investing Cash Flow
-13,324.00
-13,324.00
-19,135.00
-8,025.00
-5,601.00
Financing Cash Flow
-14,384.00
-14,384.00
-41,476.00
-36,281.00
13,368.00
End Cash Position
109,306.00
109,306.00
158,366.00
199,270.00
153,911.00
Capital Expenditure
-12,314.00
-12,314.00
-7,329.00
-5,029.00
-4,001.00
Issuance of Capital Stock
115.00
115.00
176.00
977.00
2,088.00
Issuance of Debt
--
--
--
--
25,508.00
Repayment of Debt
-1,000.00
-1,000.00
-24,734.00
-12,984.00
-4,734.00
Repurchase of Capital Stock
--
--
-5,160.00
-11,227.00
--
Free Cash Flow
-32,083.00
-32,083.00
14,383.00
82,184.00
96,424.00
12/31/2020 - 6/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8C4.F CYBERDYNE Inc.
1.0460
-2.79%
NEOLA.ST Neola Medical AB (publ)
2.5600
+0.79%
NYZ.BE Novacyt SA
0.7130
+3.78%
51KA.BE AVITA Medical Inc
8.30
-3.49%
CYBQF CYBERDYNE Inc.
1.0350
0.00%
PHIAa.XC
61MA.F MedCap AB (publ)
51.50
+2.18%
2SE.F Sequana Medical NV
2.5700
-2.65%
2SE.SG Sequana Medical NV
2.6100
-1.14%
ABT.VI Abbott Laboratories
109.48
+1.31%